Sunscreens




Ultraviolet radiation plays a major role in the development of nonmelanoma and melanoma skin cancers. Photoprotection by sunscreens has been shown to prevent the development of actinic keratosis, squamous cell carcinoma, melanoma, and photoaging. However, these benefits are only derived if the users apply sunscreen appropriately and practice other sun protection measures. This review discusses the health benefits provided by sunscreen use, updates the latest regulatory landscape on sunscreen, and addresses the controversies and limitations associated with sunscreen use.


Key points








  • Regular sunscreen use prevents the development of actinic keratosis (AK), squamous cell carcinoma (SCC), melanoma, and photoaging associated with sun exposure.



  • Food and Drug Administration (FDA) final ruling on labeling and effectiveness testing adopted the critical wavelength (CW) test to assess ultraviolet (UV)-A filtering capacity; only products with CW greater than or equal to 370 nm can claim broad-spectrum status.



  • Safety profiles of sunscreens have been called into question, but current studies show that sunscreens are safe and effective.



  • Appropriate application and improved compliance remain the major challenges that limit the effectiveness of sunscreen use.






Introduction


Skin cancer is the most common cancer in the United States. Over the past decades, both the incidence and the mortality of skin cancer have been rising. Current estimates of nonmelanoma skin cancer suggest that more than 2 million Americans are affected annually and 1 in 5 Americans will be affected in their lifetime. UV light plays a major role in the development of skin cancer. Exposure to sunlight has been attributed to nearly 90% of nonmelanoma and 65% of melanoma skin cancers. Therefore, protecting from UV light is a major strategy in the prevention of skin cancer.


UV light is classified into different wavelengths: UV-C (270–290 nm), UV-B (290–320 nm), UV-A2 (320–340 nm), and UV-A1 (340–400 nm). UV-C is filtered by the ozone layer and does not reach the surface of the earth. Compared to UV-B radiation, UV-A penetrates deeper into the skin and reaches the dermis. The intensity of UV radiation that reaches the skin depends on several environmental factors including latitude, altitude, season, cloudiness, and time of day. As UV radiation travels through the skin, DNA, lipids, and proteins absorb UV energy causing direct and indirect damage to nearby structures. High-energy UV-B rays cause direct damage to DNA by creating covalent bonds between pyrimidine bases. These bonds have a high mutagenic potential and need to be corrected by DNA repair mechanisms. Indirect damage is caused by both UV-A and UV-B light, resulting in the formation of reactive oxygen species, oxidative DNA damage, and activation of inflammatory cytokines. Ultimately, these molecular insults result in sunburns, pigment darkening, suppression of cellular immunity, premature aging, and photocarcinogenesis.


Over the past decades, there has been an increased effort by the health care community to promote healthy sun-related attitudes and behaviors. Comprehensive sun protection includes minimizing sun exposure by using photoprotective gear such as long-sleeved shirts, wide-brimmed hats, and sunglasses and by applying sunscreen regularly ( Box 1 ). Among these measures, sunscreens are one of the most popular protective methods used by the public. This review discusses the health benefits afforded by sunscreen use, reviews the impact of the 2011 FDA ruling on sunscreen labeling and effectiveness testing, and addresses the controversies and limitations associated with sunscreen use.



Box 1





  • Seek shade and minimize sun exposure, especially between 10 am and 2 pm



  • Wear photoprotective clothing, including a wide-brimmed hat, long-sleeve shirt, pants, and sunglasses



  • Use a broad-spectrum sunscreen with an SPF of 15 or more daily



  • For extended outdoor activity, use a water-resistant, broad-spectrum sunscreen with an SPF of 30 or more



  • Apply 1 oz of sunscreen to the entire body 15 minutes before going outside



  • When outdoor, reapply sunscreen at least every 2 hours, or immediately after swimming or excessive sweating



Patient recommendations for comprehensive photoprotection




Introduction


Skin cancer is the most common cancer in the United States. Over the past decades, both the incidence and the mortality of skin cancer have been rising. Current estimates of nonmelanoma skin cancer suggest that more than 2 million Americans are affected annually and 1 in 5 Americans will be affected in their lifetime. UV light plays a major role in the development of skin cancer. Exposure to sunlight has been attributed to nearly 90% of nonmelanoma and 65% of melanoma skin cancers. Therefore, protecting from UV light is a major strategy in the prevention of skin cancer.


UV light is classified into different wavelengths: UV-C (270–290 nm), UV-B (290–320 nm), UV-A2 (320–340 nm), and UV-A1 (340–400 nm). UV-C is filtered by the ozone layer and does not reach the surface of the earth. Compared to UV-B radiation, UV-A penetrates deeper into the skin and reaches the dermis. The intensity of UV radiation that reaches the skin depends on several environmental factors including latitude, altitude, season, cloudiness, and time of day. As UV radiation travels through the skin, DNA, lipids, and proteins absorb UV energy causing direct and indirect damage to nearby structures. High-energy UV-B rays cause direct damage to DNA by creating covalent bonds between pyrimidine bases. These bonds have a high mutagenic potential and need to be corrected by DNA repair mechanisms. Indirect damage is caused by both UV-A and UV-B light, resulting in the formation of reactive oxygen species, oxidative DNA damage, and activation of inflammatory cytokines. Ultimately, these molecular insults result in sunburns, pigment darkening, suppression of cellular immunity, premature aging, and photocarcinogenesis.


Over the past decades, there has been an increased effort by the health care community to promote healthy sun-related attitudes and behaviors. Comprehensive sun protection includes minimizing sun exposure by using photoprotective gear such as long-sleeved shirts, wide-brimmed hats, and sunglasses and by applying sunscreen regularly ( Box 1 ). Among these measures, sunscreens are one of the most popular protective methods used by the public. This review discusses the health benefits afforded by sunscreen use, reviews the impact of the 2011 FDA ruling on sunscreen labeling and effectiveness testing, and addresses the controversies and limitations associated with sunscreen use.



Box 1





  • Seek shade and minimize sun exposure, especially between 10 am and 2 pm



  • Wear photoprotective clothing, including a wide-brimmed hat, long-sleeve shirt, pants, and sunglasses



  • Use a broad-spectrum sunscreen with an SPF of 15 or more daily



  • For extended outdoor activity, use a water-resistant, broad-spectrum sunscreen with an SPF of 30 or more



  • Apply 1 oz of sunscreen to the entire body 15 minutes before going outside



  • When outdoor, reapply sunscreen at least every 2 hours, or immediately after swimming or excessive sweating



Patient recommendations for comprehensive photoprotection




Mechanism of action


Sunscreens provide temporary protection against UV radiation. The active ingredients are classified into organic and inorganic UV filters based on chemical composition and mechanism of action. Organic filters are aromatic compounds that work by absorbing UV light, and inorganic filters are minerals that can absorb, reflect, and scatter UV light ( Fig. 1 ). There are advantages and disadvantages associated with both kinds of filters, and it is not infrequent to see both types of filters present in commercially available formulations.




Fig. 1


Sunscreens’ mechanism of action. Organic UV filters absorb energy from UV radiation causing electrons in the filter to jump to an excited state. On return to ground state, energy is released in the form of heat or light in longer wavelength. Transition back to ground state has the potential of causing chemical modifications, resulting in filters that are less effective at filtering UV light. Inorganic UV filters can absorb, reflect, and scatter UV light. Compared to organic filters, these products are more stable to degradation from UV exposure.


Organic UV filters exert their protective effects by absorbing high-energy photons from UV radiation. The energy absorbed is transmitted to electrons, which jump to an excited state, and on return to ground state, release their energy in the form of heat or light in longer wavelength. p -Aminobenzoic acid was the first UV filter available in the United States but had many undesirable properties. It was known for its potential to cause photoallergic, contact dermatitis and stain clothes. Newer generations of organic filters have improved safety and sensory profiles and extended coverage to the UV-A range.


At present, there are 15 organic UV filters approved for use in the United States ( Table 1 ). At this time, avobenzone is the only organic filter approved by the FDA that has long-range UV-A (340–400 nm) protection. Its absorption profile ranges from 310 nm to 400 nm, with an absorption peak around 360 nm. Avobenzone is known for being intrinsically unstable and degrades after 1 hour of UV exposure. To maintain its efficacy, it must be combined with a photostabilizer, which facilitates the transition from an excited state back to ground state. Without the presence of a photostabilizer, the avobenzone molecule in its excited state can isomerize and fragment into compounds that are less effective at filtering UV light.



Table 1

Ultraviolet light filters approved by FDA for use In United States


































































































Active Ingredient Maximum λ (nm) Absorption UV Spectrum Coverage
Organic UV filters UV-B filters Aminobenzoates
para- Aminobenzoic acid 283 UV-B
Padimate O (octyl dimethyl PABA) 311 UV-B
Cinnamates
Cinoxate (2-ethoxyethyl p- methoxycinnamate) 289 UV-B
Octinoxate (octyl methoxycinnamate) 311 UV-B
Salicylates
Trolamine salicylate (triethanolamine salicylate) 260–355 UV-B
Homosalate (homomenthyl salicylate) 306 UV-B
Octisalate (octyl salicylate) 307 UV-B
Others
Octocrylene (2-ethylhexyl 2-cyano-3,3- diphenylacrylate) 303 UV-B, UV-A2
Ensulizole (phenylbenzimidazole sulfonic acid) 310 UV-B
UV-A filters Benzophenones
Oxybenzone (benzophenone-3) 288, 325 UV-B, UV-A2
Dioxybenzone (benzophenone-8) 352 UV-B, UV-A2
Sulisobenzone (benzophenone-4) 366 UV-B, UV-A2
Dibenzoylmethanes
Avobenzone (butyl methoxydibenzoylmethane, Parsol 1789) 360 UV-A1
Anthralates
Meradimate (menthyl anthranilate) 340 UV-A2
Camphors
Ecamsule (terephthalylidene dicamphor sulfonic acid, Mexoryl SX) 345 UV-B, UV-A
Inorganic UV filters Zinc oxide Depends on particle size UV-B, UV-A
Titanium dioxide Depends on particle size UV-B, UV-A

Abbreviation: PABA, para-Aminobenzoic acid.

Data from U.S. Food and Drug Administration. Sunscreen drug products for over-the-counter human use [stayed indefinitely]. 21 CFR 352. Available at: http://www.gpo.gov/fdsys/pkg/CFR-2002-title21-vol5/pdf/CFR-2002-title21-vol5-sec352-10.pdf . Revised April 1, 2013. Effective June 4, 2004. Accessed September 1, 2013.


Zinc oxide (ZnO) and titanium dioxide (TiO 2 ) are the only inorganic UV filters approved for use in the United States (see Table 1 ). Early generations of these products lacked popularity because of inherent flaws in their sensory profiles. These early-generation products contained larger particles with higher refractive indices resulting in a thick, white coat that had poor particle dispersion and comedogenic potential. Over the past few decades, manufacturers have modified formulations to include microsized and nanosized ZnO and TiO 2 , which scatter less visible light and create more transparent films that provide improved cosmetic appearance. The reduction in particle size has also led to changes in the absorption profile. Nanosized TiO 2 has an enhanced ability to absorb UV light in the UV-B range (ie, 290–320 nm). However, this increase in UV-B absorption may result in decreased protection from UV-A radiation and potential loss of broad-spectrum coverage. Compared to organic filters, these filters are less susceptible to degradation from UV exposure and have a lower potential of causing allergic reactions.




Health benefits of using sunscreen


Sunscreen use has been shown to impart many health benefits. Studies have demonstrated that using sunscreen on a daily basis can prevent the development of AK, SCC, and melanoma. Furthermore, there is evidence suggesting that sunscreens can diminish the appearance of premature aging and prevent exacerbations of photodermatoses. Much of the information that we have today on the protective effects of sunscreens has been derived from the Nambour Skin Cancer Prevention Trial in Australia. This series of studies, initiated in 1992, was conducted using a sunscreen with sun protection factor (SPF) 16 containing 2% 4- tert -butyl-4′-methoxy-4-dibenzolymethane (avobenzone) and 8% 2-ethylhexyl- p -methoxycinnamate (octinoxate) as active ingredients. This formulation is not photostable and will not pass the new FDA standards to be labeled broad spectrum. Nonetheless, the fact that this sunscreen reduced the incidence of skin cancer suggests that modern-day sunscreens with a higher SPF value and broad-spectrum protection may likely provide even greater health benefits.


Prevention of AK and SCC


AKs are well-known risk factors for the development of nonmelanoma skin cancer, and nearly 65% of SCCs arise from previously diagnosed actinic lesions. Several studies have explored the effect of sunscreen use on the development of AKs. Thompson and colleagues used a randomized controlled trial to study the incidence, prevalence, and remission rates of AKs. These investigators supplied participants with broad-spectrum SPF 17 sunscreen containing 2% avobenzone and 8% octinoxate or a base cream containing no active ingredients. Over the span of 7 months, the study showed that daily sunscreen use reduced the emergence of new lesions, decreased the total number of AKs, and induced greater remission rates, all in a dose-dependent manner. Darlington and colleagues also evaluated the prevalence of AKs. These investigators assessed the rate of change in the incidence of AKs among participants from the Nambour Skin Cancer Prevention Trial in Australia. They found that daily use of broad-spectrum, SPF 16 sunscreen resulted in a 24% reduction in the average rate of AK development. In addition, their study revealed a greater reduction in the rate of AK acquisition among participants who had fewer baseline AKs, suggesting that sunscreen use might be more effective at preventing, rather than inducing remission of AKs.


SCC commonly occurs on sun-exposed areas of the body in fair-skinned individuals. Both AK and SCC are associated with high-dose cumulative UV exposure. There is strong evidence supporting the use of sunscreen as a safe and effective method to prevent SCC. In a randomized controlled trial of 1621 adults who lived in Nambour, Australia, participants were assigned either to an intervention group that was provided with SPF 16 sunscreen containing 2% avobenzone and 8% octinoxate for daily use or to a control group that was allowed to use sunscreen at their discretion. After a 4.5-year intervention, the study showed a statistically significant 38% reduction in the incidence of SCC tumors among participants assigned to the sunscreen group. Both cohorts were followed up for another 8 years after the completion of the first 4.5 years; the same investigators reported similar protective effects of daily sunscreen use in the same cohort of participants. Although most of this effect may be attributed to the use of sunscreen during the original trial, many of the participants in the intervention group continued to use sunscreen more frequently during the follow-up period.


Reduction of Basal Cell Carcinoma


Basal cell carcinoma (BCC) accounts for up to 80% of all skin cancers, and sun exposure has been identified as a risk factor for the development of these tumors. The relationship between UV light and BCC development is complex. Most BCC tumors arise on chronically sun-damaged skin involving the face, head, and neck areas, but about one-third of tumors develop in areas with minimal sun exposure, such as the trunk and lower limbs, suggesting that other factors are involved in tumorigenesis. To date, the previously mentioned Nambour Skin Cancer Prevention Trial in Australia has been the only randomized controlled study to look at the effect of sunscreen use on BCC development. The results of this study did not reveal a significant difference in BCC prevalence between the groups studied. However, the follow-up study conducted by van der Pols and colleagues 8 years later showed a 25% reduction in BCC incidence among participants previously assigned to the sunscreen group. This trend was also not statistically significant. Several explanations have been proposed to explain these results. First, BCC has a latency period of more than 20 years from the time of UV damage to the clinical onset of disease. The study by van der Pols and colleagues, demonstrated a trend toward decreased BCC incidence, indicating that longer periods of follow-up may be needed to observe the protective effect of sunscreen use in BCC development. In addition, the design of both studies allowed participants in the control group to use sunscreen at their discretion. In fact, about 25% of the participants in the control group used sunscreen as regularly as participants in the intervention group, implying that the results of the study may have been diluted by the behavior of the control group. In conclusion, sunscreens may be beneficial in preventing BCC development; however, further studies are needed to clearly delineate this effect.


Prevention of Melanoma


Melanoma results from a multifactorial process involving both genetic and environmental predispositions. UV radiation has been identified as the only modifiable risk factor for the development of melanoma. High-dose intermittent sun exposure associated with sunburns carries a lifetime relative risk for melanoma of up to 1.6 across all age groups. Despite the established etiologic role of UV exposure on the development of melanoma, evidence to support the use of sunscreen as a preventative method has been historically ambiguous and controversial. A meta-analysis was conducted by Dennis and colleagues evaluating all cohort and case-control studies published between 1966 and 2003. This study revealed neither a protective nor a harmful association between sunscreen use and melanoma. In 2010, Green and colleagues published the first randomized control study to evaluate the protective effects of sunscreen use on the development of melanoma. This study looked at melanoma as a secondary endpoint, 10 years after the conclusion of the Nambour Skin Cancer Prevention Trial. The investigators found a 50% reduction in new primary melanomas and a 73% reduction in invasive melanoma rates among participants previously assigned to the sunscreen group. This landmark study demonstrated that regular sunscreen use reduces the risk of developing melanoma. It is important to highlight that the investigators followed up the cohort for more than 15 years in this study.


Prevention of Skin Aging


Photoaging is a complex and progressive process exacerbated by UV exposure. Among the treatments available, sunscreens are considered the most effective at preventing photoaging. Data to support this concept comes from a randomized controlled trial conducted by Hughes and colleagues among participants in the Nambour Skin Cancer Prevention Trial, who were younger than 55 years. These investigators obtained skin surface replicas of the dorsal part of the left hand of the participants and graded the microtopography. Each unit increase in microtopography grade correlates with visible signs of skin aging, such as deterioration of skin texture and increase in visible small blood vessels and comedones on the face, as well as with the risk of developing AKs and nonmelanoma skin cancer. Hughes and colleagues found that daily sunscreen use reduces the likelihood of having higher microtopography grades and also decreases the risk of developing AKs and skin cancer.


Management of Photodermatoses


Polymorphous light eruption (PMLE) is a common photodermatosis characterized by highly pruritic and polymorphous skin lesions resulting from exposure to sunlight. The disease reduces quality of life because of physical appearance of lesions and pruritus. The mainstay in management of PMLE includes sun avoidance, regardless of the severity of disease. Patients are encouraged to adopt a comprehensive sun protection regimen if they must be outside, including daily use of broad-spectrum sunscreen with SPF greater than 30 that is applied generously and frequently. Schleyer and colleagues analyzed the efficacy of sunscreens with high UV-A and UV-B protection in the development of PMLE lesions after standardized photoprovocation. A total of 12 patients were treated with UV-A, UV-B, or both UV-A and UV-B light at sites where either broad-spectrum sunscreen containing several UV-A and UV-B filters or vehicle cream without active ingredients were applied. In 10 of these patients, PMLE lesions were provoked in the placebo sites, while sites pretreated with sunscreen were fully protected from PMLE. Ultimately, the results of this study show that high-SPF, broad-spectrum sunscreen can successfully prevent the development of PMLE.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 12, 2018 | Posted by in Dermatology | Comments Off on Sunscreens

Full access? Get Clinical Tree

Get Clinical Tree app for offline access